DXB 3.19% 45.5¢ dimerix limited

On slide #13, it has been mentioned that "DMX-200 is the only...

  1. 32 Posts.
    lightbulb Created with Sketch. 1
    On slide #13, it has been mentioned that "DMX-200 is the only therapy in phase 3 development". However, a quick search showed that FILSPARI® (sparsentan) is also in phase 3. From one website, my understanding is it is for IgA nephropathy; however, another website mentioned FSGS, too. Can anyone shed some light on this?
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.